We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

152 hedge funds and large institutions have $796M invested in Dr. Reddy's Laboratories in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,691% more call options, than puts

Call options by funds: $394K | Put options by funds: $22K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 150 → 152 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $812M → $796M (-$16.1M)

4% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 53

2.03% less ownership

Funds ownership: 65.23% → 63.2% (-2%)

Holders
152
Holders Change
+2
Holders Change %
+1.33%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
51
Reduced
53
Closed
16
Calls
$394K
Puts
$22K
Net Calls
+$372K
Net Calls Change
+$342K

Top Buyers

Rank Fund Capital Flow
1
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
+$15.9M
2
Goldman Sachs
Goldman Sachs
New York
+$10.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
4
Marshall Wace
Marshall Wace
United Kingdom
+$5.42M
5
MWNA
Marshall Wace North America
New York
+$5.32M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$9.2M
2
Swiss National Bank
Swiss National Bank
Switzerland
-$5.31M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.79M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4.63M
5
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
51
Victory Capital Management
Texas
$1.93M +$1.89M +254,610 New
CCM
52
Causeway Capital Management
California
$1.78M +$187K +25,165 +12%
Morgan Stanley
53
Morgan Stanley
New York
$1.67M +$996K +133,895 +155%
PHAM
54
Portland Hill Asset Management
United Kingdom
$1.54M -$19.9K -2,680 -1%
Legal & General Group
55
Legal & General Group
United Kingdom
$1.51M – – –
SAM
56
Sectoral Asset Management
Quebec, Canada
$1.49M – – –
Zurich Cantonal Bank
57
Zurich Cantonal Bank
Switzerland
$1.46M -$655K -88,000 -31%
HSBC Holdings
58
HSBC Holdings
United Kingdom
$1.32M -$241K -32,390 -16%
Barclays
59
Barclays
United Kingdom
$1.26M +$481K +64,700 +64%
QI
60
Qtron Investments
Massachusetts
$1.17M – – –
Connor, Clark & Lunn Investment Management (CC&L)
61
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.11M +$673K +90,500 +162%
MWA
62
Marshall Wace Asia
Hong Kong
$1.1M +$1.08M +145,735 New
Stifel Financial
63
Stifel Financial
Missouri
$969K -$7.85K -1,055 -0.8%
HJIM
64
Henry James International Management
New York
$951K +$1.12K +150 +0.1%
Nordea Investment Management
65
Nordea Investment Management
Sweden
$941K +$170K +22,805 +23%
Principal Financial Group
66
Principal Financial Group
Iowa
$934K +$139K +18,705 +18%
Fidelity Investments
67
Fidelity Investments
Massachusetts
$879K -$714K -95,990 -45%
BDS
68
Banco de Sabadell
Florida
$850K – – –
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$759K -$96.3K -12,945 -11%
Bank of New York Mellon
70
Bank of New York Mellon
New York
$729K -$303K -40,755 -30%
Axa
71
Axa
France
$714K -$38.3K -5,145 -5%
Two Sigma Advisers
72
Two Sigma Advisers
New York
$697K -$18.6K -2,500 -3%
AA
73
ALPS Advisors
Colorado
$619K -$22.3K -2,995 -4%
Citadel Advisors
74
Citadel Advisors
Florida
$611K -$1.03M -138,075 -63%
LNWWM
75
Laird Norton Wetherby Wealth Management
California
$610K +$44.7K +6,010 +8%
1 2
3
4 5

RDY Hedge Fund Activity: Q3 2019 in Review

152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2019, worth a combined $796M — down 2% from $812M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RDY positions and 16 closed out — a net gain of 2 holders — while 51 added to existing stakes and 53 trimmed.

The largest buyer was Mitsubishi UFJ Trust & Banking, adding an estimated $15.9M. The largest seller was BlackRock, cutting an estimated $9.2M.

  • 152 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2019, up from 150 in Q2 2019.
  • Funds reported $796M of Dr. Reddy's Laboratories stock for Q3 2019, down 2% quarter-over-quarter.
  • 18 funds opened new Dr. Reddy's Laboratories positions in Q3 2019 and 16 closed out, a net change of +2 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2019 was Mitsubishi UFJ Trust & Banking, an estimated $15.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2019 was BlackRock, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2019.